Filtering by:
Prostate CancerMore Black Women Die from Breast Cancer Than Any Other Cancer
New Cancer Facts & Figures for African American/Black People finds breast cancer now surpasses lung as the leading cause of cancer death in Black women.
Risk of Dying from Cancer Continues to Drop at an Accelerated Pace
New 2022 cancer facts and figures show overall improvement, with new milestones for early detection of lung cancer, but with slowing progress for prostate and breast cancer.
Study Takes the Call for Cancer Screenings to the Pulpit
Cherly Knott, PhD, developed Project HEAL to help raise awareness about cancer prevention and screening for breast, prostate, & colorectal cancer. Learn more.
Facts & Figures 2021 Reports Another Record-Breaking 1-Year Drop in Cancer Deaths
Read the Cancer Facts & Figures 2021, for the latest estimates, information and statistics for deaths related to cancer.
Study: Hormone Treatment for Prostate Cancer Linked With Dementia
Researchers from the University of Pennsylvania found that older prostate cancer patients getting hormone treatment, called androgen deprivation therapy (ADT), were more likely to be diagnosed later with Alzheimer’s disease or dementia.
Prostate Cancer Survivor Reflects on Life After Treatment: ‘I’m still me.’
Brian Glennon says he’s still the same Sinatra-loving, Broadway-going, basketball-coaching 63-year-old man who is grateful for the love of his family. Glennon was diagnosed with prostate cancer after a higher-than-average PSA result prompted him and his doctor to monitor his PSA level more closely.
Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years
The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.
New Prostate Cancer Guideline Offers Shortened Radiation Time
Men being treated for early-stage prostate cancer with external beam radiation therapy (EBRT) can safely choose an option that reduces the number of treatment sessions, according to a panel of experts from the American Society for Radiation Oncology, American Society of Clinical Oncology, and American Urological Association.